The estimated Net Worth of John B Green is at least 197 千$ dollars as of 20 April 2020. John Green owns over 25,624 units of Verastem Inc stock worth over 126,126$ and over the last 11 years John sold VSTM stock worth over 71,240$.
Sign up
John Green VSTM stock SEC Form 4 insiders trading
John has made over 14 trades of the Verastem Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently John exercised 25,624 units of VSTM stock worth 139,651$ on 20 April 2020.
The largest trade John's ever made was exercising 47,969 units of Verastem Inc stock on 17 January 2020 worth over 142,468$. On average, John trades about 6,109 units every 90 days since 2013. As of 20 April 2020 John still owns at least 45,045 units of Verastem Inc stock.
You can see the complete history of John Green stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's John Green's mailing address?
John's mailing address filed with the SEC is C/O DICERNA PHARMACEUTICALS, INC., 33 HAYDEN AVENUE, LEXINGTON, MA, 02421.
Insiders trading at Verastem Inc
Over the last 13 years, insiders at Verastem Inc have traded over 5,883,823$ worth of Verastem Inc stock and bought 3,873,819 units worth 28,318,633$ . The most active insiders traders include Capital Management, L.P.Ra ...、Christoph H Westphal、Ansbert Gadicke. On average, Verastem Inc executives and independent directors trade stock every 28 days with the average trade being worth of 112,479$. The most recent stock trade was executed by Dan Paterson on 5 August 2024, trading 3,245 units of VSTM stock currently worth 7,009$.
What does Verastem Inc do?
verastem, inc. (nasdaq: vstm) is a biopharmaceutical company focused on discovering and developing novel drugs that selectively target cancer stem cells. cancer stem cells are an underlying cause of tumor recurrence and metastasis. verastem is translating breakthrough discoveries in cancer stem cell research into new medicines for the treatment of major cancers such as breast cancer. for more information, please visit www.versatem.com
What does Verastem Inc's logo look like?
Complete history of John Green stock trades at Dicerna Pharmaceuticals Inc、Verastem Inc
Verastem Inc executives and stock owners
Verastem Inc executives and other stock owners filed with the SEC include:
-
Brian Stuglik,
Chief Executive Officer, Director -
Daniel Paterson,
President, Chief Operating Officer -
Robert Gagnon,
Chief Financial Officer, Chief Business Officer -
Brian M. Stuglik BPHARM, R.Ph., RPh,
CEO & Director -
Brian Stuglik R.Ph., RPh,
CEO & Director -
Daniel W. Paterson,
COO & Pres -
Robert E. Gagnon,
Chief Bus. & Financial Officer -
Michael Kauffman,
Lead Independent Director -
Timothy Barberich,
Independent Director -
Eric Rowinsky,
Independent Director -
Alison Lawton,
Independent Director -
Bruce Wendel,
Independent Director -
Gina Consylman,
Independent Director -
John Doyle,
Investor Relations -
Dr. Michelle Dipp M.D., Ph.D.,
Co-Founder -
Sean C. Flynn,
VP, Gen. Counsel & Sec. -
Erin S. Cox,
Sr. Director of Investor Relations & Corp. Communications -
Dr. Jonathan Pachter Ph.D.,
Chief Scientific Officer -
Dr. Michelle Dipp,
Co-Founder -
Dr. Piyush B. Gupta Ph.D.,
Co-Founder -
Dr. Robert A. Weinberg,
nder & Former Chair of Scientific Advisory Board -
Richard H. Aldrich M.B.A., Mba,
Founder and Consultant -
S. Louise Phanstiel,
Director -
Joseph Chiapponi,
Vice President of Finance -
John B Green,
Chief Financial Officer -
Monica Singh,
General Counsel -
Henri A Termeer,
Director -
Stephen A Sherwin,
Director -
Christoph H Westphal,
Executive Chairman -
Paul A Friedman,
Director -
Karin Anna Tollefson,
Director -
Steven H. Bloom,
Chief Strategy Officer -
Julie B Feder,
Chief Financial Officer -
Robert Forrester,
President and CEO -
Ngoc Diep T. Md, Ph D Le,
Chief Medical Officer -
Joseph M Lobacki,
Executive VP & CCO -
Gregory Berk,
Chief Medical Officer -
Capital Investments L.P.Rid...,
-
Capital Management, L.P.Ra ...,
-
John Johnson,
Director -
Management Co. Llc Deer,
Director -
Iii Lp Chp,
10% owner -
John K Clarke,
Director -
Joanna Horobin,
Chief Medical Officer -
Jonathan Pachter,
VP, Head of Research -
Fund, L.P. Longwood,
10% owner -
Venture Partners Vii L.P.Be...,
-
Stephen Kraus,
Director -
Ansbert Gadicke,
Director -
Bioventures V Llcmpm Bioven...,
-
Piyush Gupta,
10% owner -
Iii Lpchp Iii Management, L...,
-
Daniel Calkins,
Chief Financial Officer -
Frank Neumann,
Chief Medical Officer -
Paul A. Bunn,
Director -
Lesley Kim Solomon,
Director -
Michelle Robertson,
Director -
Anil Kapur,
Director -
Dan Paterson,
President and CEO